Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tgf pkc'

Search results for: 'research area tgf pkc'

Items 11-19 of 19

Page
per page
  1. Tamoxifen
    B5965 Tamoxifen
     1 Citation
    Target: PKC
    Summary: TGF-β modulatory and PKC inhibitory effects
      ≥18.6 mg/mL
  2. Dequalinium Chloride
    B2191 Dequalinium Chloride
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: anti-tumor agent and PKC inhibitor
      insoluble in H2O; insoluble in ETOH; insoluble in DMSO
  3. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  4. Rottlerin
    B6803 Rottlerin
     1 Citation
    Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2
    Summary: PKC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥23.6 mg/mL
  5. LY364947
    B2287 LY364947
     1 Citation
    Summary: inhibitor of TGF-β type I receptor kinase domain
      insoluble in EtOH; insoluble in H2O; ≥24.4 mg/mL
  6. EW-7197
    B5946 EW-7197
     1 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective inhibitor of TGF-β type I receptor kinase
      ≥39.9 mg/mL
  7. PD 173074
    A8253 PD 173074
    Target: VEGFR|FGFR
    Summary: FGFR inhibitor
      ≥26.18 mg/mL
  8. CYC116
    A4125 CYC116
    Target: Aurora Kinases|FLT3|VEGFR
    Summary: Potent Aurora A/B inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
  9. GSK690693
    A5072 GSK690693
    Target: Akt|PKC|PKG|PKA|Prk
    Summary: Pan-AKT inhibitor,ATP-competitive and potent
      ≥21.25 mg/mL

Items 11-19 of 19

Page
per page